Microbiology of nonbullous impetigo

Pediatric Dermatology

Volumn 14, Issue 3, 1997, Pages 192-195

  Brook, Itzhak ^a,b   Frazier, Edith H ^a   Yeager, Josef K ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BACTEROIDES FRAGILIS; CHILD; CLINICAL ARTICLE; ESCHERICHIA COLI; FUSOBACTERIUM; HUMAN; IMPETIGO; INFANT; PEPTOSTREPTOCOCCUS; PREVOTELLA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A;

EID: 0030916039     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.1997.tb00235.x     Document Type: Article

References (21)

1. Peter G, Smith AL. Group A streptococcal infections of the skin and pharynx (first of two parts). N Engl J Med 1977; 297:311-317.
2. Dagan R, Bar-David Y. Comparison of amoxicillin and clavulanic acid (Augmentin) for the treatment of nonbullous impetigo. Am J Dis Child 1989;143:916-918.
3. Summanen P, Baron EJ, Citron DM, Strong CA, Wexler HM, Finegold SM. Wadsworth anaerobic bacteriology manual, 5th ed. Belmont, CA: Star Publishing, 1993.
4. Murray PR, Baron EJ, Pfalter MA, Tenover FC, Yol Ren RH. Manual of clinical microbiology, 6th ed. Washington, DC: American Society for Microbiology, 1995.
5. O'Callaghan DH, Morris A, Kirby SM, Shingler AH. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972;1:283-288.
6. Darmstadt GL, Lane AT. Impetigo: an overview. Pediatr Dermatol 1994;11:293-303.
7. Barton LL, Friedman AD. Impetigo: a reassessment of etiology and therapy. Pediatr Dermatol 1987;3:185-188.
8. Drasar DR, Hill MJ. Human intestinal flora. London: Academic Press, 1975.
9. Socransky SS, Manganiello SD. The oral microbiota of man from birth to senility. J Periodontol 1971;42:485-196.
10. Brook I. Pediatric anaerobic infections: diagnosis and management, 2nd ed. Philadelphia: Mosby, 1989.
11. Finegold SM. Anaerobic bacteria in human disease. Orlando, FL: Academic Press, 1977.
12. Meislin HW, Lerner SA, Gravis MH, et al. Cutaneous abscesses: aerobic and anaerobic bacteriology and outpatient management. Ann Intern Med 1977;97:145-150.
13. Brook I, Finegold SM. Aerobic and anaerobic bacteriology of cutaneous abscess in children. Pediatrics 1981;67:891-895.
14. Meleney FL. Bacterial synergy in disease processes. Ann Surg 1931;22:961-981.
15. Brook I. Enhancement of growth of aerobic and facultative bacteria in mixed infection with Bacteroides species. Infect Immunol 1985;50:929-931.
16. Ingham HR, Tharagonnet D, Sisson PR. Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet 1977;i: 252-254.
17. Lev M, Krudell KC, Milford AF. Succinate as a growth factor for Bacteroides melaninogenicus. J Bacteriol 1971; 108:175-178.
18. Mergenhagen SE, Thonard JC, Scherp HW. Studies on synergistic infection: I. Experimental infection with anaerobic streptococci. J Infect Dis 1958;103:33-44.
19. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984:6:601-607.
20. Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol 1995;33:2382-2387.
21. Brook I. Frazier EH. Clinical features and aerobic and anaerobic characteristics of cellulitis. Arch Surg 1995;130: 786-792.